• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CSL

CSL LIMITED

0.46% ! $257.60
Market Cap $124.7B  !

CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus... CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The Company operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others. More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CSL
Csl is now a bargain
3 4 5
10:24 276 127K
10:24 Last post  W534220 Comments Created with Sketch.  276  Views Created with Sketch.  127K 
CSL 10:21 1 332
10:21 Last post  W534220 Comments Created with Sketch.  1  Views Created with Sketch.  332 
CSL
Biotech stocks that survived April 2 feel the heat of Trump's new pharma threat
30/04/25 27 13K
Metals & Mining SECTOR NEWS

Final Phase assays from Eastern Goldfields Project

RC1
05 May 2025
REDCASTLE RESOURCES LIMITED
30/04/25 Last post  optimistus Comments Created with Sketch.  27  Views Created with Sketch.  13K 
CSL
,-Signs-an-Agreement-with-the-European-Commission-to-Support-Pandemic-Preparedness-Plans
30/04/25 0 228
30/04/25 Last post  W534220 Comments Created with Sketch.  0  Views Created with Sketch.  228 
CSL
CSL survives a brutal sell-off but dips on US tariff response as investors eye pharma risk
13/04/25 13 5.5K
13/04/25 Last post  W534220 Comments Created with Sketch.  13  Views Created with Sketch.  5.5K 
CSL
$200 soon
11/04/25 19 10K
11/04/25 Last post  bagus Comments Created with Sketch.  19  Views Created with Sketch.  10K 
CSL 10/04/25 0 335
10/04/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  335 
CSL
China claims that albumin can be created in rice
09/04/25 4 2.0K
09/04/25 Last post  Macrosoft Comments Created with Sketch.  4  Views Created with Sketch.  2.0K 

See All Discussions arrow Created with Sketch.

Timeline

Shareholder Information Meetings
05 May 08:26
 
Notification of cessation of securities - CSL
10 Apr 10:01
 
CSL Responds to Proposed USA Tariffs
03 Apr 11:22
 
Change of Director's Interest Notice
17 Mar 12:21
 
Notification of cessation of securities - CSL
13 Mar 10:33
 
Update - Dividend/Distribution - CSL
13 Mar 09:01
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$257.60
Change
1.190(0.46%)
Mkt cap ! $124.7B
Open High Low Value Volume
$256.99 $258.85 $255.87 $82.53M 320.5K

Buyers (Bids)

No. Vol. Price($)
3 19 $257.54
 

Sellers (Offers)

Price($) Vol. No.
$257.59 14 1
View Market Depth
Last trade - 15.36pm 05/05/2025 (20 minute delay) ?
Last
$257.45
  Change
1.190 ( 0.35 %)
Open High Low Volume
$256.96 $258.73 $255.93 20268
Last updated 15.55pm 05/05/2025 ?
CSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.